Diabetes decision-support tools
DreaMed develops tools for diabetes management.
Source: LinkedIn company description · Retrieved October 13, 2026
Its products are based on insights from the clinical practice of diabetes specialists, physicians, and clinical researchers at diabetes centers worldwide. The company says it received FDA clearance for a decision-support system using CGM/SMBG and insulin-pump data.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
DreaMed develops tools for diabetes management.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 4, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 14, 2026, September 18, 2026, September 19, 2026, September 20, 2026, September 27, 2026, September 29, 2026 and September 30, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.